These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 33844832)

  • 21. Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type.
    Malpas CB; Saling MM; Velakoulis D; Desmond P; Hicks RJ; Zetterberg H; Blennow K; O'Brien TJ
    J Alzheimers Dis; 2018; 62(1):417-427. PubMed ID: 29439322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Apolipoprotein E4, a Genetic Risk Factor for Alzheimer's Disease].
    Kikuchi M; Nakaya A
    Brain Nerve; 2019 Oct; 71(10):1053-1060. PubMed ID: 31588049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does traumatic brain injury hold the key to the Alzheimer's disease puzzle?
    Becker RE; Kapogiannis D; Greig NH
    Alzheimers Dement; 2018 Apr; 14(4):431-443. PubMed ID: 29245000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime.
    Gamba P; Leonarduzzi G; Tamagno E; Guglielmotto M; Testa G; Sottero B; Gargiulo S; Biasi F; Mauro A; Viña J; Poli G
    Aging Cell; 2011 Jun; 10(3):403-17. PubMed ID: 21272192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress.
    Rosales-Corral S; Tan DX; Manchester L; Reiter RJ
    Oxid Med Cell Longev; 2015; 2015():985845. PubMed ID: 25815110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
    Tijms BM; Gobom J; Reus L; Jansen I; Hong S; Dobricic V; Kilpert F; Ten Kate M; Barkhof F; Tsolaki M; Verhey FRJ; Popp J; Martinez-Lage P; Vandenberghe R; Lleó A; Molinuevo JL; Engelborghs S; Bertram L; Lovestone S; Streffer J; Vos S; Bos I; ; Blennow K; Scheltens P; Teunissen CE; Zetterberg H; Visser PJ
    Brain; 2020 Dec; 143(12):3776-3792. PubMed ID: 33439986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can dementia patients live in a community? A case of a patient in trouble with the law.
    Shoji M; Takada J; Nakashima F; Meguro K
    Psychogeriatrics; 2019 Nov; 19(6):605-608. PubMed ID: 30883996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inositol trisphosphate 3-kinase B is increased in human Alzheimer brain and exacerbates mouse Alzheimer pathology.
    Stygelbout V; Leroy K; Pouillon V; Ando K; D'Amico E; Jia Y; Luo HR; Duyckaerts C; Erneux C; Schurmans S; Brion JP
    Brain; 2014 Feb; 137(Pt 2):537-52. PubMed ID: 24401760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease.
    Broom GM; Shaw IC; Rucklidge JJ
    Nutrition; 2019 Apr; 60():118-121. PubMed ID: 30554068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
    Carter CJ
    Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiproteinopathy, neurodegeneration and old age: a case study.
    Rojas JC; Stephens ML; Rabinovici GD; Kramer JH; Miller BL; Seeley WW
    Neurocase; 2018 Feb; 24(1):1-6. PubMed ID: 29307276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current challenges for the successful treatment and prevention of Alzheimer's disease: treating the pathologies of the disease to change its clinical course.
    Schenk D
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S119-21. PubMed ID: 18631987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions.
    Klupp E; Förster S; Grimmer T; Tahmasian M; Yakushev I; Sorg C; Yousefi BH; Drzezga A
    Brain Connect; 2014 Jun; 4(5):371-83. PubMed ID: 24870443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model.
    Ezra A; Rabinovich-Nikitin I; Rabinovich-Toidman P; Solomon B
    J Alzheimers Dis; 2016; 50(1):175-88. PubMed ID: 26682687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.
    Gauthier S; Feldman HH; Schneider LS; Wilcock GK; Frisoni GB; Hardlund JH; Moebius HJ; Bentham P; Kook KA; Wischik DJ; Schelter BO; Davis CS; Staff RT; Bracoud L; Shamsi K; Storey JM; Harrington CR; Wischik CM
    Lancet; 2016 Dec; 388(10062):2873-2884. PubMed ID: 27863809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms.
    Lin YF; Smith AV; Aspelund T; Betensky RA; Smoller JW; Gudnason V; Launer LJ; Blacker D
    Alzheimers Dement; 2019 Jan; 15(1):65-75. PubMed ID: 30240575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
    Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Rodriguez JL; Snellman A; Suárez-Calvet M; Zetterberg H; Blennow K; Schöll M;
    Brain; 2021 Feb; 144(1):325-339. PubMed ID: 33257949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammalian Target of Rapamycin at the Crossroad Between Alzheimer's Disease and Diabetes.
    Liang H; Nie J; Van Skike CE; Valentine JM; Orr ME
    Adv Exp Med Biol; 2019; 1128():185-225. PubMed ID: 31062331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.